Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 7, 2012, Pages 917-923

  Sunpath, Henry ^a,b   Edwin, C ^a   Chelin, N ^a   Nadesan, S ^a   Maharaj, R ^a   Moosa, Y ^b   Smeaton, L ^c   Court, R ^d   Knight, S ^e   Gwyther, E ^d   Murphy, R A ^f  

^a MCCORD HOSPITAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antiviral therapy; Operational research; Resource limited settings

Indexed keywords

EFAVIRENZ; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL PNEUMONIA; CD4 LYMPHOCYTE COUNT; CHRONIC DIARRHEA; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; DRUG EFFICACY; EARLY INTERVENTION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENTION TO TREAT ANALYSIS; KIDNEY DISEASE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TOXOPLASMOSIS; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; OPERATIONS RESEARCH; RETROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS;

EID: 84862170749     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0651     Document Type: Article

References (16)

1. Murphy R A, Sunpath H, Taha B, et al. Low uptake of anti-retroviral therapy after admission with human immunodefi ciency virus and tuberculosis in KwaZulu-Natal, South A frica. Int J Tuberc Lung Dis 2010; 14: 903-908.
2. World Health Organization/Joint United Nations Programme on HIV/AIDS/United Nations of International Children's Emergency Fund. Towards universal access: scaling up priority interventions in the health sector. Progress report April 2007. http//www.who.int/hiv/mediacentre/universal-access- progress-report-en.pdf Accessed February 2012.
3. Coovadia A, Venter F. Criteria for expedited antiretroviral initiation and emergency triage. S Afr J HIV Med 2009; 33: 27-28.
4. Zolopa A R, Andersen J, Komarow L, et al. Early antiretroviral therapy reduces aids progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE 2009; 4: e5575.
5. Havlir D, Ive P, Kendall M, et al., and A5521 Team. International randomized trial of immediate vs. early ART in HIV+ patients treated for TB: ACTG 5221 STRIDE Study. Boston, MA, USA: 18th Conference on Retroviruses and Opportunistic Infections, 27 February-2 March, 2011. [Abstract #38]
6. Abdool Karim S S, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011; 365: 1492-1501.
7. Blanc F X, Sok T, Laureillard D, Borand L, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011; 365: 1471-1481.
8. Makadzange A T, Ndhlovu C E, Takarinda K, et al. Early v ersus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-Saharan Africa. Clin Infect Dis 2010; 50: 1532-1538.
9. Grant P M, Aberg J A, Zolopa A R. Concerns regarding a r andomized study of the timing of antiretroviral therapy in Zimbabweans with AIDS with acute cryptococcal meningitis [Letter]. Clin Infect Dis 2010; 51: 984-985.
10. US Department of Health and Human Services Panel on Anti-retroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, December 1, 2009. Washington DC, USA: US DHHS, 2011. http://www.aidsinfo.nih.gov/ContentFiles/Adult and Adolescent GL.pdf Accessed February 2012.
11. Monty T, ed. McCord-Siyaphila Centre standard operating guidelines. Durban, South Africa: McCord Hospital, 2006.
12. US Department of Health and Human Services Health Resources and Services Administration HIV/AIDS Bureau Working Group on HIV and Palliative Care. Palliative and supportive care. Washington DC, USA: HRSA Care Action, 2000. http://www.hab.hrsa.gov Accessed May 2012.
13. Benson C A, Kaplan J E, Masur H, et al. Treating opportunistic infections among HIV infected adults and adolescents. MMWR 2004; 53 (RR-15): 1-112. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5315al.htm Accessed April 2012.
14. Maskew M, Brennan A T, Macphail A P, et al. Poorer ART outcomes with increasing age at a large public sector HIV clinic in Johannesburg, South Africa. J Int Assoc Physicians AIDS Care 2011; 53: 500-506.
15. Hofmeyer G P, Georgiou T, Baker C W, et al. The Keiskamma AIDS Treatment Programme: evaluation of a community based antiretroviral programme in a rural setting. S Afr J HIV Med 2009; 33: 38-41.
16. Eshun-Wilson M, Van der Plas H, Prozesky H W, et al. Combined antiretroviral treatment initiation during hospitalization: outcomes in South African adults. J Acquir Immune Defic Syndr 2009; 51: 104-106.